Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Triana Lobatón Ortega
Profile
Projects
Publications
Activities
75
Results
2023
Studying the pathogenesis of persistent fatigue in inflammatory bowel diseases
Marie Truyens
Debby Laukens
Triana Lobatón Ortega
Roosmarijn Vandenbroucke
Dissertation
2023
2022
A randomized placebo controlled clinical trial with 5-hydroxytryptophan in patients with quiescent Inflammatory Bowel Disease and fatigue (Trp-IBD)
Marie Truyens
Triana Lobatón Ortega
Gerard Gonzales
Debby Laukens
Martine De Vos
C3
Conference
2022
Effect of 5-hydroxytryptophan on fatigue in quiescent inflammatory bowel disease : a randomized controlled trial
Marie Truyens
Triana Lobatón Ortega
Tom Holvoet
Gerard Gonzales
Simon Bos
Debby Laukens
Martine De Vos
A1
Journal Article
in
GASTROENTEROLOGY
2022
Endoscopic postoperative recurrence in Crohn's disease after curative ileocecal resection with early prophylaxis by anti-TNF, vedolizumab or ustekinumab : a real-world multicenter European study
Marie Truyens
Triana Lobatón Ortega
A1
Journal Article
in
JOURNAL OF CROHNS & COLITIS
2022
Gastroenteropancreatic neuroendocrine neoplasms in patients with inflammatory bowel fisease : an ECCO CONFER multicentre case series
Triana Lobatón Ortega
Marie Truyens
A1
Journal Article
in
JOURNAL OF CROHNS & COLITIS
2022
Infliximab re-challenge : could it be an option in refractory IBD patients?
Marie Truyens
Triana Lobatón Ortega
C3
Conference
2022
Role of integrin expression in the prediction of response to vedolizumab : a prospective real‐life multicentre cohort study
Cara De Galan
Gerard Gonzales
Sophie Van Welden
Simon Tavernier
Triana Lobatón Ortega
Martine De Vos
Debby Laukens
Pieter Hindryckx
A1
Journal Article
in
CLINICAL AND TRANSLATIONAL MEDICINE
2022
The impact of vedolizumab and ustekinumab on articular extra-intestinal manifestations in inflammatory bowel disease patients : a real-life multicentric cohort study
Cara De Galan
Marie Truyens
Tom Holvoet
Gerard Gonzales
Gaëlle Varkas
Martine De Vos
Triana Lobatón Ortega
A1
Journal Article
in
JOURNAL OF CROHNS & COLITIS
2022
2021
A discriminative metabolic profile in the sera of Crohn's disease patients with fibrostenosis
Simon Bos
Martine De Vos
Pieter Hindryckx
Triana Lobatón Ortega
Lynn Vanhaecke
Debby Laukens
C3
Conference
2021
Can serum metabolomics discriminate the Crohn’s disease fibrostenotic phenotype?
Simon Bos
Sophie Van Welden
Martine De Vos
Pieter Hindryckx
Triana Lobatón Ortega
Lynn Vanhaecke
Debby Laukens
C3
Conference
2021
Early prediction of response to vedolizumab in patients with active inflammatory bowel disease : a prospective real-life multicentre cohort study
Cara De Galan
Sophie Van Welden
Simon Tavernier
Triana Lobatón Ortega
Martine De Vos
Debby Laukens
Pieter Hindryckx
C3
Conference
2021
Effectiveness of third-class biologic treatment in Crohn’s disease : a multi-center retrospective cohort study
Marie Truyens
Triana Lobatón Ortega
A1
Journal Article
in
JOURNAL OF CLINICAL MEDICINE
2021
Efficacy of anti-TNF dosing interval lengthening in adolescents and young adults with inflammatory bowel disease in sustained remission (FREE-study) : protocol for a partially randomised patient preference trial
Triana Lobatón Ortega
Stephanie Van Biervliet
A1
Journal Article
in
BMJ OPEN
2021
First results of the BELCOMID study : Belgian cohort study of COVID-19 in Immune Mediated Inflammatory Diseases (IMID)
Marie Truyens
Jo Lambert
Hilde Lapeere
Triana Lobatón Ortega
C3
Conference
2021
Gastroenteropancreatic neuroendocrine neoplasms in patients with inflammatory bowel disease : an ECCO CONFER multicentre case series
Marie Truyens
Triana Lobatón Ortega
C3
Conference
2021
Long-term environmental hypoxia does not impact experimental Crohn's like ileitis
Cara De Galan
Sophie Van Welden
Triana Lobatón Ortega
Pieter Hindryckx
Martine De Vos
Debby Laukens
C3
Conference
2021
Optimal management of acute severe ulcerative colitis (ASUC) : challenges and solutions
Tom Holvoet
Triana Lobatón Ortega
Pieter Hindryckx
A2
Journal Article
in
CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY
2021
Patient perspectives on the role of the IBD nurse and telemedicine during COVID-19 pandemic : results from a Belgian tertiary IBD unit
Marie Truyens
Triana Lobatón Ortega
C3
Conference
2021
Safety of vedolizumab and ustekinumab in elderly IBD patients : a real-life multicentric cohort study
Cara De Galan
Marie Truyens
Martine De Vos
Triana Lobatón Ortega
C3
Conference
2021
The impact of vedolizumab and ustekinumab on arthropathy and arthralgia in IBD patients : a real-life multicentric cohort study
Marie Truyens
Cara De Galan
Gaëlle Varkas
Martine De Vos
Triana Lobatón Ortega
C3
Conference
2021
2020
Effectiveness of dose escalation in Crohn's disease patients with insufficient response to standard-dose subcutaneous ustekinumab maintenance therapy : a multicentre international cohort study
Marie Truyens
Triana Lobatón Ortega
C3
Conference
2020
Effectiveness of ustekinumab dose escalation in Crohn's disease patients with insufficient response to standard-dose subcutaneous maintenance therapy
Marie Truyens
Triana Lobatón Ortega
A1
Journal Article
in
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
2020
Effectiveness of ustekinumab in refractory Crohn's disease : a real-life experience in a tertiary referral centre
Marie Truyens
Pieter Hindryckx
Triana Lobatón Ortega
C3
Conference
2020
Integrin expression changes on the T cells subsets influence the response to vedolizumab in inflammatory bowel disease patients
Cara De Galan
Sophie Van Welden
Simon Bos
Simon Tavernier
Triana Lobatón Ortega
Gerard Gonzales
Martine De Vos
Debby Laukens
Pieter Hindryckx
C3
Conference
2020
New onset spondyloarthropathy in vedolizumab treated IBD patients
Triana Lobatón Ortega
Marie Truyens
C3
Conference
2020
Safety and efficacy of combining biological therapies together or with small molecules in patients with inflammatory bowel disease : a retrospective multicentre national observational case series study
Marie Truyens
Triana Lobatón Ortega
C3
Conference
2020
The effect of age on infliximab pharmacokinetics in patients with inflammatory bowel disease
Triana Lobatón Ortega
C3
Conference
2020
The impact of vedolizumab on extra-intestinal manifestations in inflammatory bowel disease patients : a real-life experience of a single-centre cohort
Marie Truyens
Gaëlle Varkas
Dirk Elewaut
Triana Lobatón Ortega
C3
Conference
2020
Tofacitinib induces clinical and endoscopic remission in biologic refractory ulcerative colitis patients : a real-world Belgium cohort study
Triana Lobatón Ortega
C3
Conference
2020
eTofacitinib induces clinical and endoscopic remission in biologic refractory ulcerative colitis patients : a real-world Belgian cohort study
Triana Lobatón Ortega
C3
Conference
2020
2019
Effectiveness of third-class biologic treatment in Crohn's disease : a multi-center retrospective cohort study
Marie Truyens
Triana Lobatón Ortega
C3
Conference
2019
Efficacy of Ustekinumab intensification and re-induction in Crohn’s disease patients with insufficient or loss of response
Marie Truyens
Pieter Hindryckx
Triana Lobatón Ortega
C3
Conference
2019
Ileal but not colonic inflammation is linked to fatty lesions on MRI of the sacroiliac joints in spondyloarthritis patients
Ann-Sophie De Craemer
Manouk de Hooge
Thomas Renson
Liselotte Deroo
Triana Lobatón Ortega
Anne Hoorens
Philippe Carron
Filip Van den Bosch
Dirk Elewaut
C3
Conference
2019
Integrin expression changes on the T cell subsets influence the response to vedolizumab in inflammatory bowel disease patients
Cara De Galan
Sophie Van Welden
Simon Bos
Simon Tavernier
Triana Lobatón Ortega
Gerard Gonzales
Martine De Vos
Debby Laukens
Pieter Hindryckx
C3
Conference
2019
Nivolumab-induced immune-mediated colitis : an ulcerative colitis look-alikereport of new cases and review of the literature
Triana Lobatón Ortega
A1
Journal Article
in
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
2019
Relevant infections in inflammatory bowel disease, and their relationship with immunosuppressive therapy and their effects on disease mortality
Triana Lobatón Ortega
A1
Journal Article
in
JOURNAL OF CROHNS & COLITIS
2019
Retrospective study of the effectiveness and safety of Ustekinumab in refractory Crohn's Disease
Marie Truyens
Pieter Hindryckx
Triana Lobatón Ortega
C3
Conference
2019
Young GI angle : should I go abroad?
Triana Lobatón Ortega
Other
2019
2018
Editorial : infliximab trough levels and histological healing in ulcerative colitis-a step towards personalised biologic therapy
Triana Lobatón Ortega
Editorial material
2018
Long-term safety of in utero exposure to anti-TNF alpha drugs for the treatment of inflammatory bowel disease : results from the Multicenter European TEDDY Study
Triana Lobatón Ortega
A1
Journal Article
in
AMERICAN JOURNAL OF GASTROENTEROLOGY
2018
New methylation biomarker panel for early diagnosis of dysplasia or cancer in high-risk inflammatory bowel disease patients
Triana Lobatón Ortega
A1
Journal Article
in
INFLAMMATORY BOWEL DISEASES
2018
Primoinfección por citomegalovirus en enfermedad inflamatoria intestinal
Triana Lobatón Ortega
Editorial material
2018
Prognostic value of histological activity in patients with ulcerative colitis in deep remission : a prospective multicenter study
Triana Lobatón Ortega
A1
Journal Article
in
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL
2018
Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre la utilidad de la determinación de calprotectina fecal en la enfermedad inflamatoria intestinal
Triana Lobatón Ortega
A1
Journal Article
in
GASTROENTEROLOGIA Y HEPATOLOGIA
2018
Uncertain usefulness of infliximab trough levels for therapeutic decision-making in inflammatory bowel disease patients on infliximab maintenance therapy
Triana Lobatón Ortega
C3
Conference
2018
2017
A simplified Geboes score for ulcerative colitis
Triana Lobatón Ortega
A1
Journal Article
in
JOURNAL OF CROHNS & COLITIS
2017
Acute histological inflammatory activity is associated with clinical relapse in patients with ulcerative colitis in clinical and endoscopic remission
Triana Lobatón Ortega
A1
Journal Article
in
DIGESTIVE AND LIVER DISEASE
2017
Epstein-Barr virus-positive mucocutaneous ulcer in Crohn's disease : a condition to consider in immunosuppressed IBD patients
Triana Lobatón Ortega
A1
Journal Article
in
DIGESTIVE AND LIVER DISEASE
2017
Long term outcome of ulcerative colitis patients responders to cyclosporine in the biological era
Triana Lobatón Ortega
C3
Conference
2017
Long-term outcome of ulcerative colitis patients responders to cyclosporine in the biological era
Triana Lobatón Ortega
C3
Conference
2017
Long-term safety of in utero exposure to anti-tumor necrosis factor for the treatment of inflammatory bowel diseases : results from the multicenter European TEDDY study
Triana Lobatón Ortega
C3
Conference
2017
Real-life infliximab trough levels among inflammatory bowel disease patients on maintenance therapy : should we redefine therapeutic range based on inflammatory load?
Triana Lobatón Ortega
C3
Conference
2017
The availability of infliximab trough levels in IBD patients on maintenance therapy deeply impacts therapeutic decision-making
Triana Lobatón Ortega
C3
Conference
2017
Therapeutic requirements in active ulcerative proctitis : a single-centre study
Triana Lobatón Ortega
A1
Journal Article
in
GASTROENTEROLOGIA Y HEPATOLOGIA
2017
2016
Bacterial intestinal superinfections in inflammatory bowel diseases beyond Clostridum difficile
Triana Lobatón Ortega
A1
Journal Article
in
INFLAMMATORY BOWEL DISEASES
2016
Predicting outcomes to optimize disease management in inflammatory bowel diseases
Triana Lobatón Ortega
A1
Journal Article
in
JOURNAL OF CROHNS & COLITIS
2016
Validation of the simplified Geboes score for ulcerative colitis
Triana Lobatón Ortega
C3
Conference
2016
2015
A simplified histological geboes score for ulcerative colitis
Triana Lobatón Ortega
C3
Conference
2015
Aeromonas species : an opportunistic enteropathogen in patients with inflammatory bowel diseases? A single center cohort study
Triana Lobatón Ortega
A1
Journal Article
in
INFLAMMATORY BOWEL DISEASES
2015
An urgent referral strategy for symptomatic patients with suspected colorectal cancer based on a quantitative immunochemical faecal occult blood test
Triana Lobatón Ortega
A1
Journal Article
in
DIGESTIVE AND LIVER DISEASE
2015
Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease
Triana Lobatón Ortega
A1
Journal Article
in
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
2015
High within-day variability of fecal calprotectin levels in patients with active ulcerative colitis : what is the best timing for stool sampling?
Triana Lobatón Ortega
A1
Journal Article
in
INFLAMMATORY BOWEL DISEASES
2015
The Modified Mayo Endoscopic Score (MMES) : a new index for the assessment of extension and severity of endoscopic activity in ulcerative colitis patients
Triana Lobatón Ortega
A1
Journal Article
in
JOURNAL OF CROHNS & COLITIS
2015
2014
Fecal level of calprotectin identifies histologic inflammation in patients with ulcerative colitis in clinical and endoscopic remission
Triana Lobatón Ortega
A1
Journal Article
in
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2014
Long-term comparative efficacy of cyclosporine- or infliximab-based strategies for the management of steroid-refractory ulcerative colitis attacks
Triana Lobatón Ortega
A1
Journal Article
in
INFLAMMATORY BOWEL DISEASES
2014
Relationship between methylation and colonic inflammation in inflammatory bowel disease
Triana Lobatón Ortega
A1
Journal Article
in
WORLD JOURNAL OF GASTROENTEROLOGY
2014
Review article : anti-adhesion therapies for inflammatory bowel disease
Triana Lobatón Ortega
A1
Journal Article
in
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
2014
2013
A new rapid quantitative test for fecal calprotectin predicts endoscopic activity in ulcerative colitis
Triana Lobatón Ortega
A1
Journal Article
in
INFLAMMATORY BOWEL DISEASES
2013
Calprotectina fecal en el diagnóstico de enfermedades inflamatorias
Triana Lobatón Ortega
A1
Journal Article
in
GASTROENTEROLOGIA Y HEPATOLOGIA
2013
Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel disease
Triana Lobatón Ortega
A1
Journal Article
in
DIGESTIVE DISEASES AND SCIENCES
2013
Comparison of the long-term outcome of two therapeutic strategies for the management of abdominal abscess complicating Crohn's disease : percutaneous drainage or immediate surgical treatment
Triana Lobatón Ortega
A1
Journal Article
in
COLORECTAL DISEASE
2013
Contribution of the SPECT and SPECT/CT with radiolabeled leucocytes in the evaluation of the inflammatory bowel disease
Triana Lobatón Ortega
C3
Conference
2013
Novel methylation panel for the early detection of neoplasia in high-risk ulcerative colitis and Crohn's Colitis patients
Triana Lobatón Ortega
A1
Journal Article
in
INFLAMMATORY BOWEL DISEASES
2013
2010
Antibiotic-resistant bacteria in spontaneous bacterial peritonitis : is it time to change?
Triana Lobatón Ortega
C3
Conference
2010
2009
Usefulness of reagent strips for checking cure in spontaneous bacterial peritonitis after short-course treatment
Triana Lobatón Ortega
A1
Journal Article
in
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
2009